Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Total Non-Current Liabilities (2021 - 2024)

Skinvisible's (SKVI) quarterly Total Non-Current Liabilities came in at $9.4 million in Q4 2024, up 2.09% year-over-year from $9.2 million in Q1 2024, and down 6.49% quarter-over-quarter from $10.0 million in Q3 2024.

Analysis

Skinvisible (SKVI) Total Non-Current Liabilities (2021 - 2024) Analysis & Trends

Skinvisible has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $9.4 million for Q4 2024.

  • In Q4 2024, Total Non-Current Liabilities rose 2.09% year-over-year to $9.4 million; the TTM figure through Dec 2024 stood at $9.4 million (up 2.09% YoY), while the FY2024 annual figure was $9.4 million, up 2.09% from the prior year.
  • Total Non-Current Liabilities came in at $9.4 million for Q4 2024 at Skinvisible, down from $10.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $10.0 million in Q3 2024 to a low of $5.0 million in Q1 2021.
  • Average Total Non-Current Liabilities over 4 years is $7.5 million, with a median of $7.6 million recorded in 2022.
  • Year-over-year, Total Non-Current Liabilities jumped 44.2% in 2023 and increased 2.09% in 2024.
  • Over 4 years, Total Non-Current Liabilities stood at $5.6 million in 2021, then grew by 22.8% to $6.9 million in 2022, then soared by 33.37% to $9.2 million in 2023, then gained by 2.09% to $9.4 million in 2024.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $9.4 million in Q4 2024, $10.0 million in Q3 2024, and $9.7 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 646.03 Bn 625.27 Bn 17.26 Bn 105.99 Bn
2 AbbVie 441.56 Bn 434.99 Bn 12.70 Bn 106.45 Bn
3 Merck 364.45 Bn 357.31 Bn 12.21 Bn 16.16 Bn
4 Novartis Ag 267.46 Bn 259.77 Bn 11.24 Bn 48.34 Bn
5 Pfizer 158.77 Bn 147.08 Bn 10.94 Bn 100.86 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn 32.04 Bn
7 Revolution Medicines 44.15 Bn 44.15 Bn - 1.53 Bn
8 Incyte 25.31 Bn 20.77 Bn 1.57 Bn 1.40 Bn
9 United Therapeutics 21.29 Bn 18.63 Bn 683.80 Mn 607.80 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 9.36 Mn
Sep 30, 2024 10.01 Mn
Jun 30, 2024 9.73 Mn
Mar 31, 2024 9.45 Mn
Dec 31, 2023 9.17 Mn
Sep 30, 2023 8.89 Mn
Jun 30, 2023 8.62 Mn
Mar 31, 2023 8.34 Mn
Dec 31, 2022 6.87 Mn
Sep 30, 2022 6.50 Mn
Jun 30, 2022 6.12 Mn
Mar 31, 2022 5.79 Mn
Dec 31, 2021 5.60 Mn
Sep 30, 2021 5.41 Mn
Jun 30, 2021 5.15 Mn
Mar 31, 2021 5.02 Mn